Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 23 | 2024 | 473 | 4.700 |
Why?
|
| Superoxide Dismutase | 22 | 2022 | 210 | 3.040 |
Why?
|
| Motor Neurons | 12 | 2022 | 206 | 2.080 |
Why?
|
| RNA Interference | 11 | 2011 | 587 | 1.560 |
Why?
|
| Spinal Cord | 10 | 2024 | 195 | 1.340 |
Why?
|
| Mutation | 14 | 2022 | 2418 | 1.310 |
Why?
|
| RNA, Small Interfering | 11 | 2011 | 849 | 1.230 |
Why?
|
| Mice, Transgenic | 18 | 2022 | 1218 | 1.120 |
Why?
|
| Citrullination | 2 | 2024 | 33 | 1.080 |
Why?
|
| Neurodegenerative Diseases | 4 | 2022 | 125 | 1.050 |
Why?
|
| Transgenes | 3 | 2011 | 170 | 0.920 |
Why?
|
| Mice | 34 | 2024 | 10184 | 0.900 |
Why?
|
| Mitochondria | 6 | 2006 | 327 | 0.890 |
Why?
|
| Profilins | 4 | 2022 | 45 | 0.890 |
Why?
|
| Gene Silencing | 6 | 2009 | 376 | 0.840 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 669 | 0.820 |
Why?
|
| DNA-Binding Proteins | 3 | 2014 | 1125 | 0.790 |
Why?
|
| Disease Models, Animal | 11 | 2022 | 2039 | 0.780 |
Why?
|
| Animals | 41 | 2024 | 19483 | 0.780 |
Why?
|
| Nerve Degeneration | 3 | 2016 | 68 | 0.770 |
Why?
|
| Genetic Techniques | 2 | 2011 | 40 | 0.630 |
Why?
|
| Superoxide Dismutase-1 | 14 | 2022 | 134 | 0.620 |
Why?
|
| Neurofilament Proteins | 3 | 2002 | 16 | 0.570 |
Why?
|
| Axonal Transport | 3 | 2022 | 31 | 0.560 |
Why?
|
| Phenotype | 3 | 2016 | 1150 | 0.550 |
Why?
|
| Genetic Therapy | 5 | 2011 | 698 | 0.540 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 119 | 0.530 |
Why?
|
| RNA Polymerase II | 2 | 2006 | 70 | 0.500 |
Why?
|
| Neurons | 3 | 2011 | 853 | 0.470 |
Why?
|
| Peroxisomes | 2 | 2004 | 10 | 0.460 |
Why?
|
| Vacuoles | 2 | 2004 | 27 | 0.460 |
Why?
|
| Promoter Regions, Genetic | 3 | 2006 | 653 | 0.450 |
Why?
|
| Drosophila Proteins | 2 | 2022 | 678 | 0.450 |
Why?
|
| Integrases | 2 | 2011 | 36 | 0.450 |
Why?
|
| Armadillo Domain Proteins | 1 | 2013 | 20 | 0.440 |
Why?
|
| Gliosis | 2 | 2024 | 27 | 0.440 |
Why?
|
| Myelin Proteins | 2 | 2024 | 30 | 0.440 |
Why?
|
| Protein Aggregates | 2 | 2024 | 17 | 0.440 |
Why?
|
| Myelin Sheath | 2 | 2024 | 35 | 0.430 |
Why?
|
| Spermatogenesis | 1 | 2013 | 64 | 0.430 |
Why?
|
| Genes, Dominant | 2 | 2010 | 55 | 0.420 |
Why?
|
| Luminescent Proteins | 3 | 2008 | 128 | 0.420 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2012 | 10 | 0.410 |
Why?
|
| MicroRNAs | 6 | 2014 | 617 | 0.390 |
Why?
|
| Drosophila melanogaster | 3 | 2013 | 478 | 0.380 |
Why?
|
| Genetic Vectors | 4 | 2011 | 788 | 0.370 |
Why?
|
| Green Fluorescent Proteins | 6 | 2010 | 350 | 0.370 |
Why?
|
| Dependovirus | 3 | 2014 | 647 | 0.350 |
Why?
|
| Central Nervous System | 4 | 2014 | 190 | 0.340 |
Why?
|
| Disease Progression | 4 | 2022 | 1029 | 0.330 |
Why?
|
| Animals, Genetically Modified | 4 | 2014 | 281 | 0.330 |
Why?
|
| Adenoviridae | 1 | 2009 | 119 | 0.320 |
Why?
|
| Molecular Chaperones | 2 | 2007 | 94 | 0.300 |
Why?
|
| Humans | 27 | 2024 | 58820 | 0.300 |
Why?
|
| Mitochondrial Diseases | 2 | 2004 | 22 | 0.280 |
Why?
|
| Membrane Proteins | 1 | 2013 | 835 | 0.280 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 193 | 0.280 |
Why?
|
| Electron Transport | 2 | 2002 | 28 | 0.260 |
Why?
|
| Transfection | 4 | 2011 | 670 | 0.260 |
Why?
|
| Base Sequence | 6 | 2011 | 1308 | 0.250 |
Why?
|
| Models, Genetic | 1 | 2006 | 253 | 0.250 |
Why?
|
| RNA, Small Nuclear | 1 | 2003 | 25 | 0.220 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2024 | 85 | 0.220 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 50 | 0.220 |
Why?
|
| Hydrolases | 1 | 2024 | 80 | 0.210 |
Why?
|
| Spastin | 1 | 2022 | 3 | 0.210 |
Why?
|
| Pick Disease of the Brain | 1 | 2022 | 5 | 0.210 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 9 | 0.210 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 16 | 0.210 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2022 | 53 | 0.200 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 846 | 0.200 |
Why?
|
| RNA | 1 | 2006 | 400 | 0.200 |
Why?
|
| Dendrites | 1 | 2002 | 56 | 0.200 |
Why?
|
| Cell Line | 5 | 2008 | 2011 | 0.200 |
Why?
|
| Histocytochemistry | 1 | 2002 | 48 | 0.200 |
Why?
|
| Alleles | 3 | 2012 | 424 | 0.200 |
Why?
|
| Axons | 2 | 2012 | 120 | 0.200 |
Why?
|
| Motor Neuron Disease | 1 | 2002 | 29 | 0.200 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 1972 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 192 | 0.190 |
Why?
|
| Research Design | 1 | 2005 | 561 | 0.190 |
Why?
|
| Blotting, Western | 3 | 2011 | 591 | 0.190 |
Why?
|
| Peripheral Nerves | 1 | 2001 | 27 | 0.180 |
Why?
|
| Frontotemporal Dementia | 1 | 2022 | 126 | 0.180 |
Why?
|
| RNA, Messenger | 4 | 2010 | 1460 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2006 | 130 | 0.170 |
Why?
|
| Nucleic Acid Conformation | 3 | 2006 | 231 | 0.170 |
Why?
|
| Proteins | 1 | 2024 | 741 | 0.150 |
Why?
|
| Cloning, Molecular | 2 | 2010 | 384 | 0.150 |
Why?
|
| Recombination, Genetic | 2 | 2011 | 236 | 0.150 |
Why?
|
| Blotting, Northern | 2 | 2011 | 148 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 498 | 0.140 |
Why?
|
| Mutant Proteins | 3 | 2013 | 103 | 0.140 |
Why?
|
| 3' Untranslated Regions | 2 | 2008 | 84 | 0.140 |
Why?
|
| Introns | 2 | 2008 | 106 | 0.140 |
Why?
|
| Paralysis | 1 | 2016 | 16 | 0.140 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2016 | 17 | 0.140 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 26 | 0.140 |
Why?
|
| Gene Dosage | 1 | 2016 | 60 | 0.140 |
Why?
|
| Cytoskeleton | 1 | 2016 | 140 | 0.130 |
Why?
|
| Gene Transfer Techniques | 2 | 2011 | 304 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2006 | 1975 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 2016 | 214 | 0.120 |
Why?
|
| Biomarkers | 3 | 2022 | 1199 | 0.110 |
Why?
|
| Meiosis | 1 | 2013 | 62 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2006 | 304 | 0.110 |
Why?
|
| Gene Expression | 1 | 2016 | 804 | 0.110 |
Why?
|
| Infertility, Male | 1 | 2013 | 58 | 0.110 |
Why?
|
| Antibody Specificity | 1 | 2013 | 99 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2013 | 280 | 0.110 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2003 | 31 | 0.110 |
Why?
|
| Testis | 1 | 2013 | 135 | 0.110 |
Why?
|
| Electron Transport Complex IV | 2 | 2002 | 13 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2013 | 565 | 0.100 |
Why?
|
| Vesicular Transport Proteins | 1 | 2013 | 103 | 0.100 |
Why?
|
| Epitopes | 1 | 2013 | 298 | 0.100 |
Why?
|
| HeLa Cells | 2 | 2011 | 527 | 0.100 |
Why?
|
| Reverse Transcription | 1 | 2011 | 7 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2011 | 3156 | 0.090 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 82 | 0.090 |
Why?
|
| Astrocytes | 1 | 2011 | 113 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2012 | 2090 | 0.090 |
Why?
|
| Exons | 1 | 2010 | 192 | 0.090 |
Why?
|
| RNA Splicing | 1 | 2010 | 155 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 522 | 0.080 |
Why?
|
| Gene Targeting | 2 | 2006 | 82 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 661 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 1360 | 0.080 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2008 | 1 | 0.080 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2008 | 3 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 30 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 864 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 44 | 0.070 |
Why?
|
| RNA Stability | 1 | 2008 | 91 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2008 | 97 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2007 | 85 | 0.070 |
Why?
|
| Computer-Aided Design | 1 | 2006 | 26 | 0.070 |
Why?
|
| DNA Polymerase II | 1 | 2006 | 8 | 0.070 |
Why?
|
| Tetracycline | 1 | 2006 | 20 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 111 | 0.070 |
Why?
|
| Nucleotides | 1 | 2006 | 41 | 0.070 |
Why?
|
| DNA Polymerase III | 1 | 2006 | 27 | 0.070 |
Why?
|
| S-Nitrosothiols | 1 | 2006 | 2 | 0.070 |
Why?
|
| Luciferases | 1 | 2006 | 109 | 0.070 |
Why?
|
| Ovum | 1 | 2006 | 61 | 0.060 |
Why?
|
| Plasmids | 1 | 2006 | 279 | 0.060 |
Why?
|
| Fertilization | 1 | 2006 | 81 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 161 | 0.060 |
Why?
|
| Ubiquitin C | 1 | 2005 | 2 | 0.060 |
Why?
|
| DNA Primers | 1 | 2006 | 292 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1289 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 150 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 418 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 397 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 727 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 379 | 0.060 |
Why?
|
| Survival Rate | 1 | 2006 | 783 | 0.060 |
Why?
|
| RNA Polymerase III | 1 | 2003 | 8 | 0.060 |
Why?
|
| RNA, Antisense | 1 | 2003 | 48 | 0.060 |
Why?
|
| Female | 4 | 2013 | 30545 | 0.060 |
Why?
|
| Drosophila | 2 | 2022 | 416 | 0.050 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2003 | 67 | 0.050 |
Why?
|
| Neuronal Outgrowth | 1 | 2022 | 10 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 500 | 0.050 |
Why?
|
| Electron Transport Complex II | 1 | 2002 | 3 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 159 | 0.050 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2002 | 17 | 0.050 |
Why?
|
| Spectrophotometry | 1 | 2002 | 30 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2003 | 99 | 0.050 |
Why?
|
| Succinate Dehydrogenase | 1 | 2002 | 12 | 0.050 |
Why?
|
| Point Mutation | 1 | 2003 | 162 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2002 | 16 | 0.050 |
Why?
|
| RNA, Untranslated | 1 | 2003 | 101 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 88 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2002 | 65 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 391 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 77 | 0.050 |
Why?
|
| Posterior Horn Cells | 1 | 2002 | 4 | 0.050 |
Why?
|
| Anterior Horn Cells | 1 | 2002 | 6 | 0.050 |
Why?
|
| Tetanus Toxoid | 1 | 2022 | 14 | 0.050 |
Why?
|
| Male | 4 | 2014 | 27258 | 0.050 |
Why?
|
| Apoptosis | 1 | 2007 | 1034 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 542 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 252 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 220 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1535 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 162 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 251 | 0.050 |
Why?
|
| Sulfur Radioisotopes | 1 | 2001 | 12 | 0.050 |
Why?
|
| Protein Folding | 1 | 2022 | 256 | 0.050 |
Why?
|
| Methionine | 1 | 2001 | 56 | 0.050 |
Why?
|
| Tubulin | 1 | 2001 | 73 | 0.040 |
Why?
|
| Genotype | 1 | 2002 | 641 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2013 | 761 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 246 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2006 | 5096 | 0.030 |
Why?
|
| Base Pair Mismatch | 2 | 2006 | 36 | 0.030 |
Why?
|
| Base Pairing | 2 | 2006 | 36 | 0.030 |
Why?
|
| Callithrix | 1 | 2014 | 18 | 0.030 |
Why?
|
| Primates | 1 | 2014 | 40 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2013 | 18 | 0.030 |
Why?
|
| Time Factors | 1 | 2001 | 3544 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 115 | 0.030 |
Why?
|
| Jews | 1 | 2012 | 14 | 0.030 |
Why?
|
| Growth Cones | 1 | 2012 | 14 | 0.030 |
Why?
|
| Exome | 1 | 2012 | 72 | 0.030 |
Why?
|
| Pedigree | 1 | 2012 | 190 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 103 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 248 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 255 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 229 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1576 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1542 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1113 | 0.020 |
Why?
|
| SMN Complex Proteins | 1 | 2007 | 5 | 0.020 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2007 | 18 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2006 | 31 | 0.020 |
Why?
|
| Base Composition | 1 | 2006 | 27 | 0.020 |
Why?
|
| Purines | 1 | 2006 | 38 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2006 | 56 | 0.020 |
Why?
|
| S-Nitrosoglutathione | 1 | 2006 | 1 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2006 | 4 | 0.020 |
Why?
|
| Nitrogen | 1 | 2006 | 24 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2006 | 170 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 547 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 1475 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 2005 | 18 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 106 | 0.020 |
Why?
|
| Copper | 1 | 2006 | 49 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2003 | 59 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 124 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1090 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2003 | 107 | 0.010 |
Why?
|
| RNA Helicases | 1 | 2003 | 88 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 601 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 286 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 728 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 857 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 1136 | 0.010 |
Why?
|